Chae-Yong Kim
Overview
Explore the profile of Chae-Yong Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
162
Citations
3219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Ryoo N, Han S, Ji S, Hwang K, Han J, et al.
Neurol Sci
. 2025 Mar;
PMID: 40067403
Objectives: To evaluate the sustained effects of the cerebrospinal fluid (CSF) tap test (TT) on gait parameters over one month in patients with idiopathic normal pressure hydrocephalus (iNPH). Methods: A...
2.
Kim J, Na H, Lee S, Kim J, Suh K, Kim S, et al.
Sci Rep
. 2025 Jan;
15(1):2171.
PMID: 39820489
Next-generation sequencing (NGS) cancer profiling has gained traction in routine clinical practice in South Korea. Here, we evaluated the use of NGS testing and genomically-matched therapies for patients with advanced...
3.
Wee C, Lee J, Lee H, Kim J, Chang J, Kang S, et al.
Cancer Res Treat
. 2024 Nov;
PMID: 39529389
Purpose: To identify a specific subgroup of patients among elderly glioblastoma patients aged 70 years or older with unmethylated MGMT promoters (eGBM-unmethylated) who would significantly benefit from the addition of...
4.
Cho S, Keam B, Lee K, Kim J, Han D, Kim H, et al.
Int Forum Allergy Rhinol
. 2024 Aug;
14(12):1882-1891.
PMID: 39162101
Objectives: To evaluate the treatment outcomes in patients with advanced-stage olfactory neuroblastoma (ONB) who received induction chemotherapy (IC). Materials And Methods: The clinical data of 38 patients with advanced-stage ONB...
5.
Suh K, Jung E, Seo J, Ji S, Hwang K, Han J, et al.
Oncologist
. 2024 Jun;
29(11):e1586-e1592.
PMID: 38940449
Background: Given the typical trajectory of glioblastoma, many patients lose decision-making capacity over time, which can lead to inadequate advance care planning (ACP) and end-of-life (EOL) care. We aimed to...
6.
Choi J, Cho I, Kim T, Kim H, Park J, Kim C
Arch Gynecol Obstet
. 2024 Jun;
310(2):673-684.
PMID: 38871966
Purpose: To determine the obstetric factors affecting the development of depressed skull fracture in neonates. Materials And Methods: This was a retrospectively cohort study on neonates born between July 2016...
7.
Cho S, Cho W, Choi D, Sim G, Jeong S, Baik S, et al.
Sci Rep
. 2024 May;
14(1):11085.
PMID: 38750084
We developed artificial intelligence models to predict the brain metastasis (BM) treatment response after stereotactic radiosurgery (SRS) using longitudinal magnetic resonance imaging (MRI) data and evaluated prediction accuracy changes according...
8.
Seo K, Hwang K, Nam K, Kim M, Song Y, Kim C
Pharmaceutics
. 2024 Apr;
16(4).
PMID: 38675227
Post-operative chemotherapy is still required for the treatment of glioblastoma (GBM), for which nanocarrier-based drug delivery has been identified as one of the most effective methods. However, the blood-brain barrier...
9.
Lee Y, Chowdhury T, Kim S, Yu H, Kim K, Kang H, et al.
Exp Mol Med
. 2024 Apr;
56(4):975-986.
PMID: 38609519
We explored the genomic events underlying central neurocytoma (CN), a rare neoplasm of the central nervous system, via multiomics approaches, including whole-exome sequencing, bulk and single-nuclei RNA sequencing, and methylation...
10.
Sim Y, Yang S, Han S, Kim Y, Hwang K, Joo J, et al.
Ear Nose Throat J
. 2024 Mar;
:1455613241234818.
PMID: 38424695
To analyze changes in olfactory function after endoscopic endonasal skull base surgery and compare performance of the olfactory questionnaire with those of conventional psychophysical tests. Patients were classified into 5...